NMIN Researcher details – NMIN – Nanomedicines Innovation Network

FR
About
News & Events
People
Research
Training
Resources
Search for...

FR
About
News & Events
People
Research
Training
Resources
Search for...

NMIN Expertise Survey

Please complete this form with details about your research & development expertise. Your information will be entered into an online database on the NMIN website to facilitate collaborative research opportunities.

Name

First

Last

Email

Institution

Nanodelivery type

lipid-based
polymer-based
inorganic
other

If you chose "other" for nanodelivery type please describe:

Targeting approach

active targeting (e.g. antibody modification of nanomedicine)
physical targeting (e.g., use of pH sensitive nanomedicine)
other

Please indicate your ACTIVE TARGETING approach:

antibody
peptide
aptamer
small molecule

Please indicate your PHYSCIAL TARGETING approach:

pH sensitive
temperature sensitive
light sensitive

Please indicate your OTHER targeting approach:

Application

drug delivery
gene delivery
peptide delivery
nano-imaging
other

What kind of drug delivery?

soluble molecules
insoluble molecules

What kind of gene delivery?

DNA
siRNA
mRNA/samRNA
ASO

What kind of nano-imaging?

diagnostics
theranostics
Fluorescent imaging
PET
SPECT
other

If you chose "other" for application, please describe:

If you chose "other" for nano-imaging, please describe:

Disease models

cancer
heart failure
rare diseases
arthritis
diabetes
infectious diseases
other

What kinds of infectious diseases?

viral infections
bacterial infections

If you chose "other" for disease models, please describe:

For your OTHER disease model work, please specify all that apply:

in vitro
organoid
in vivo xenograft model
in vivo orthotopic model
in vivo PDX model
in vivo syngeneic model
in vivo metastatic model
primary cells
human

For your CANCER work, please specify all that apply:

in vitro
organoid
in vivo xenograft model
in vivo orthotopic model
in vivo PDX model
in vivo syngeneic model
in vivo metastatic model
primary cells
human

For your HEART FAILURE work, please specify all that apply:

in vitro
organoid
in vivo xenograft model
in vivo orthotopic model
in vivo PDX model
in vivo syngeneic model
in vivo metastatic model
primary cells
human

For your RARE DISEASE work, please specify all that apply:

in vitro
organoid
in vivo xenograft model
in vivo orthotopic model
in vivo PDX model
in vivo syngeneic model
in vivo metastatic model
primary cells
human

For your ARTHRITIS work, please specify all that apply:

in vitro
organoid
in vivo xenograft model
in vivo orthotopic model
in vivo PDX model
in vivo syngeneic model
in vivo metastatic model
primary cells
human

For your DIABETES work, please specify all that apply:

in vitro
organoid
in vivo xenograft model
in vivo orthotopic model
in vivo PDX model
in vivo syngeneic model
in vivo metastatic model
primary cells
human

For your INFECTIOUS DISEASE work, please specify all that apply:

in vitro
organoid
in vivo xenograft model
in vivo orthotopic model
in vivo PDX model
in vivo syngeneic model
in vivo metastatic model
primary cells
human

Unique protocols

safety/pharmacology
microfluidics
pre-GMP & GMP manufacturing
other

Do your safety/pharmacology protocols include the following?

Pre-GLP toxicity
GLP testing

If you chose "other" for unique protocols, please describe:

Unique instrumentation in the lab:

Auxiliary expertise in pharmaceutical development

regulatory science
non-nano delivery systems
marketing expertise
HTA/eHTA
other

Please provide details regarding your auxiliary expertise

Within the area(s) of expertise you have indicated here, are you currently developing a specific technology/innovation with commercial potential?

Yes
No

Please indicate the Technology Readiness Level (TRL) of your innovation:

TRL 1
TRL 2
TRL 3
TRL 4
TRL 5
TRL 6
TRL 7
TRL 8

Click here for a description of TRL levels

Are you looking for an industry partner to advance your innovation?

Yes
No

Have you applied for a patent with regard to your innovation?

Yes
No

Please indicate the current source of core funding for the research related to your innovation:

Tri Council
industry
not-for-profit
other

Please specify the not-for-profit source of funding:

Please specify the "other" source of funding:

Twitter
LinkedIn
YouTube

Neve | Powered by WordPress